论文部分内容阅读
同步放化疗是局部晚期非小细胞肺癌的标准治疗方案,疗效明显优于序贯放化疗。诱导化疗不能改善总生存及无进展生存时间。巩固化疗尚有争议。与靶向治疗联合初步结果鼓舞人心。该文主要对以上内容进行综述。
Chemoradiotherapy is a standard treatment for locally advanced non-small cell lung cancer with significantly better efficacy than sequential chemoradiation. Induction chemotherapy can not improve the overall survival and progression-free survival time. Consolidation of chemotherapy is controversial. Preliminary results in combination with targeted therapy are encouraging. This article mainly summarizes the above contents.